Work

Obeticholic acid (OCA) improves experimental non-invasive markers of NASH and advanced fibrosis: results of a secondary analysis from the month-18 interim analysis of the REGENERATE study

Year: 2020

Type: conference-paper

Source: Zeitschrift für Gastroenterologie

DOI: 10.1055/s-0040-1716157

Authors: J Schattenberg, J Boursier, R Loomba, Anstee QM, S Harrison, A Sanyal, M Rinella, Younossi ZY, Z. Goodman, P Bedossa, C Fournier, M Stenkilsson, R Shringarpure, L. Zaru, A Venugopal, L Mac Conell, V Ratziu

Institutions: University Medical Center of the Johannes Gutenberg University Mainz, Centre Hospitalier Universitaire d'Angers, University of California San Diego, Newcastle University, Pinnacle Clinical Research, Virginia Commonwealth University, Northwestern University, Inova Health System, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Echosens (France), Intercept Pharmaceuticals (United States), Sorbonne Université, Pitié-Salpêtrière Hospital

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3089259934

FWCI:

Cites:

Cited by:

Related to: 10